{"id":"W2144216228","doi":"10.1200/jco.2009.25.9606","title":"Choice of Starting Dose for Molecularly Targeted Agents Evaluated in First-in-Human Phase I Cancer Clinical Trials","year":2010,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":58,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Maximum tolerated dose; Medicine; Clinical trial; Therapeutic index; Cancer; Toxicity; Effective dose (radiation); Pharmacology; Limiting; Oncology; Internal medicine; Nuclear medicine; Drug","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.2872653,0.0007824951,0.03113052,0.0006869975,0.00006114935,0.00003346773,0.001586897,0.005184491,0.0006443987],"category_scores_gemma":[0.9063628,0.0005548319,0.006962605,0.0007349363,0.0007126196,0.0001342218,0.0002581443,0.008258378,0.000006247647],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004157843,"about_ca_system_score_gemma":0.005819262,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006084325,"about_ca_topic_score_gemma":0.0004726925,"domain_scores_codex":[0.8869807,0.05039897,0.05943427,0.00103918,0.001230433,0.0009164084],"domain_scores_gemma":[0.279314,0.6701155,0.04717759,0.0009422879,0.001577616,0.0008730135],"domain_codex":null,"domain_gemma":"methods","domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002601364,0.0082651,0.0002871911,0.00558519,0.001348771,0.0002501738,0.0000287581,0.000004063874,0.000005306136,0.001575973,0.002085674,0.9779624],"study_design_scores_gemma":[0.04990966,0.01254269,0.0002528474,0.01735212,0.009235348,0.00001278134,0.00001332803,0.0003561018,0.000005501952,0.192217,0.717433,0.0006695904],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.006547622,0.9377735,0.0173461,0.001263565,0.02343373,0.01199573,0.001172448,0.00004153219,0.000425772],"genre_scores_gemma":[0.00009941559,0.7403395,0.2545916,0.0003291865,0.004186805,0.0002368791,0.00001246305,0.0001482555,0.00005595495],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9772928,"threshold_uncertainty_score":0.9998168,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.9418097147584127,"score_gpt":0.8078207380371335,"score_spread":0.1339889767212792,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}